Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Ongoing, advanced training
In 2021, she started taking a GLP-1 drug
GLP-1 and Hypertension GLP-1 analogues LG and exendin-4 have been investigated in multiple models of hypertension
According to the group of authors, these polyagonists are in all likelihood the next step towards a cure for diabetes and obesity. Comparable to bariatric surgery The authors report on various polyagonists that are currently being researched in clinical studies and show improved efficacy with each new generation. The latest triple agonists attack both the glucose-dependent insulinotropic peptide receptor (GIPR) and the receptors for glucagon-like peptide 1 (GLP1) and glucagon (GCG, a hormone from the pancreas)
Abstract: Sestili, P., & Fimognari, C
US$ 20.76
US$ 27.16
US$ 25.81
US$ 27.88
